Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors

Cell Reports

Volumn 13, Issue 2, 2015, Pages 267-276

  Paz Yaacov, Nurit ^a   Bazak, Lily ^a   Buchumenski, Ilana ^a   Porath, Hagit T ^a   Danan Gotthold, Miri ^a   Knisbacher, Binyamin A ^a   Eisenberg, Eli ^b   Levanon, Erez Y ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DNA; INOSINE; MICRORNA; RNA; TRANSCRIPTOME;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME MODIFICATION; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CANCER; PRIORITY JOURNAL; RNA EDITING; RNA SEQUENCE; SOMATIC MUTATION; SURVIVAL RATE; TRANSCRIPTOMICS; BREAST TUMOR; CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MUTATION; PROSTATE TUMOR; UPREGULATION;

BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MUTATION; PROSTATIC NEOPLASMS; RNA EDITING; TRANSCRIPTOME; UP-REGULATION;

EID: 84944040819     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.08.080     Document Type: Article

References (59)

1. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A.J.R., Behjati S., Biankin A.V., Bignell G.R., Bolli N., Borg A., Børresen-Dale A.-L., et al. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421. Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer ConsortiumICGC Breast Cancer Consortium, ICGC MMML-Seq ConsortiumICGC MMML-Seq Consortium, ICGC PedBrainICGC PedBrain.
2. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
3. Athanasiadis A., Rich A., Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2004, 2:e391.
4. Bahn J.H., Lee J.-H., Li G., Greer C., Peng G., Xiao X. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res. 2012, 22:142-150.
5. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
6. Bazak L., Haviv A., Barak M., Jacob-Hirsch J., Deng P., Zhang R., Isaacs F.J., Rechavi G., Li J.B., Eisenberg E., Levanon E.Y. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 2014, 24:365-376.
7. Bazak L., Levanon E.Y., Eisenberg E. Genome-wide analysis of Alu editability. Nucleic Acids Res. 2014, 42:6876-6884.
8. Blow M., Futreal P.A., Wooster R., Stratton M.R. A survey of RNA editing in human brain. Genome Res. 2004, 14:2379-2387.
9. Borchert G.M., Gilmore B.L., Spengler R.M., Xing Y., Lanier W., Bhattacharya D., Davidson B.L. Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum. Mol. Genet. 2009, 18:4801-4807.
10. Buch S.C., Kondragunta V., Branch R.A., Carr B.I. Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatol. Int. 2008, 2:95-101.
11. Burns M.B., Lackey L., Carpenter M.A., Rathore A., Land A.M., Leonard B., Refsland E.W., Kotandeniya D., Tretyakova N., Nikas J.B., et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013, 494:366-370.
12. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337. Cancer Genome Atlas Network.
13. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
14. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014, 507:315-322. Cancer Genome Atlas Research Network.
15. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014, 159:676-690. Cancer Genome Atlas Research Network.
16. Carmi S., Borukhov I., Levanon E.Y. Identification of widespread ultra-edited human RNAs. PLoS Genet. 2011, 7:e1002317.
17. Cenci C., Barzotti R., Galeano F., Corbelli S., Rota R., Massimi L., Di Rocco C., O'Connell M.A., Gallo A. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem. 2008, 283:7251-7260.
18. Chang X., Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J. Med. Genet. 2012, 49:433-436.
19. Chen L., Li Y., Lin C.H., Chan T.H.M., Chow R.K.K., Song Y., Liu M., Yuan Y.-F., Fu L., Kong K.L., et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 2013, 19:209-216.
20. Collisson E.A., Campbell J.D., Brooks A.N., Berger A.H., Lee W., Chmielecki J., Beer D.G., Cope L., Creighton C.J., Danilova L., et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014, 511:543-550. Cancer Genome Atlas Research Network.
21. Daniel C., Silberberg G., Behm M., Öhman M. Alu elements shape the primate transcriptome by cis-regulation of RNA editing. Genome Biol. 2014, 15:R28.
22. Davis C.F., Ricketts C.J., Wang M., Yang L., Cherniack A.D., Shen H., Buhay C., Kang H., Kim S.C., Fahey C.C., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 2014, 26:319-330. Cancer Genome Atlas Research Network.
23. Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29:15-21.
24. Dohmen K., Shigematsu H., Irie K., Ishibashi H. Longer survival in female than male with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2003, 18:267-272.
25. Eggington J.M., Greene T., Bass B.L. Predicting sites of ADAR editing in double-stranded RNA. Nat. Commun. 2011, 2:319.
26. Eisenberg E., Adamsky K., Cohen L., Amariglio N., Hirshberg A., Rechavi G., Levanon E.Y. Identification of RNA editing sites in the SNP database. Nucleic Acids Res. 2005, 33:4612-4617.
27. Fumagalli D., Gacquer D., Rothé F., Lefort A., Libert F., Brown D., Kheddoumi N., Shlien A., Konopka T., Salgado R., et al. Principles governing A-to-I RNA editing in the breast cancer transcriptome. Cell Rep. 2015, 13:277-289. this issue.
28. Han S.-W., Kim H.-P., Shin J.-Y., Jeong E.-G., Lee W.-C., Kim K.Y., Park S.Y., Lee D.-W., Won J.-K., Jeong S.-Y., et al. RNA editing in RHOQ promotes invasion potential in colorectal cancer. J. Exp. Med. 2014, 211:613-621.
29. Han L., Diao L., Yu S., Xu X., Li J., Zhang R., Yang Y., Werner H.M.J., Eterovic A.K., Yuan Y., et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 2015, 28:515-528. this issue.
30. Hansen T.B., Jensen T.I., Clausen B.H., Bramsen J.B., Finsen B., Damgaard C.K., Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature 2013, 495:384-388.
31. Hu X., Wan S., Ou Y., Zhou B., Zhu J., Yi X., Guan Y., Jia W., Liu X., Wang Q., et al. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing. Cancer Lett. 2015, 357:510-519.
32. Ivanov A., Memczak S., Wyler E., Torti F., Porath H.T., Orejuela M.R., Piechotta M., Levanon E.Y., Landthaler M., Dieterich C., Rajewsky N. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015, 10:170-177.
33. Karolchik D., Baertsch R., Diekhans M., Furey T.S., Hinrichs A., Lu Y.T., Roskin K.M., Schwartz M., Sugnet C.W., Thomas D.J., et al. The UCSC Genome Browser Database. Nucleic Acids Res. 2003, 31:51-54. University of California Santa Cruz.
34. Kim D.D.Y., Kim T.T.Y., Walsh T., Kobayashi Y., Matise T.C., Buyske S., Gabriel A. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 2004, 14:1719-1725.
35. Lehmann K.A., Bass B.L. The importance of internal loops within RNA substrates of ADAR1. J. Mol. Biol. 1999, 291:1-13.
36. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z.Y., Shoshan A., Pollock S.R., Sztybel D., et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 2004, 22:1001-1005.
37. Levanon E.Y., Hallegger M., Kinar Y., Shemesh R., Djinovic-Carugo K., Rechavi G., Jantsch M.F., Eisenberg E. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 2005, 33:1162-1168.
38. Li J.B., Levanon E.Y., Yoon J.-K., Aach J., Xie B., Leproust E., Zhang K., Gao Y., Church G.M. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009, 324:1210-1213.
39. Liang H., Landweber L.F. Hypothesis: RNA editing of microRNA target sites in humans?. RNA 2007, 13:463-467.
40. Liao Y., Smyth G.K., Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014, 30:923-930.
41. Maas S., Patt S., Schrey M., Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. USA 2001, 98:14687-14692.
42. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L.A., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993. Breast Cancer Working Group of the International Cancer Genome Consortium.
43. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 2010, 79:321-349.
44. Park E., Williams B., Wold B.J., Mortazavi A. RNA editing in the human ENCODE RNA-seq data. Genome Res. 2012, 22:1626-1633.
45. Paz N., Levanon E.Y., Amariglio N., Heimberger A.B., Ram Z., Constantini S., Barbash Z.S., Adamsky K., Safran M., Hirschberg A., et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007, 17:1586-1595.
46. Peng Z., Cheng Y., Tan B.C.-M., Kang L., Tian Z., Zhu Y., Zhang W., Liang Y., Hu X., Tan X., et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat. Biotechnol. 2012, 30:253-260.
47. Picardi E., Pesole G. REDItools: high-throughput RNA editing detection made easy. Bioinformatics 2013, 29:1813-1814.
48. Pinto Y., Cohen H.Y., Levanon E.Y. Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol. 2014, 15:R5.
49. Porath H.T., Carmi S., Levanon E.Y. A genome-wide map of hyper-edited RNA reveals numerous new sites. Nat. Commun. 2014, 5:4726.
50. Prasanth K.V., Prasanth S.G., Xuan Z., Hearn S., Freier S.M., Bennett C.F., Zhang M.Q., Spector D.L. Regulating gene expression through RNA nuclear retention. Cell 2005, 123:249-263.
51. Qin Y.-R., Qiao J.-J., Chan T.H.M., Zhu Y.-H., Li F.-F., Liu H., Fei J., Li Y., Guan X.-Y., Chen L. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer Res. 2014, 74:840-851.
52. Ramaswami G., Li J.B. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res. 2014, 42:D109-D113.
53. Ramaswami G., Zhang R., Piskol R., Keegan L.P., Deng P., O'Connell M.A., Li J.B. Identifying RNA editing sites using RNA sequencing data alone. Nat. Methods 2013, 10:128-132.
54. Savva Y.A., Rieder L.E., Reenan R.A. The ADAR protein family. Genome Biol. 2012, 13:252.
55. Shoshan E., Mobley A.K., Braeuer R.R., Kamiya T., Huang L., Vasquez M.E., Salameh A., Lee H.J., Kim S.J., Ivan C., et al. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat. Cell Biol. 2015, 17:311-321.
56. Vitali P., Scadden A.D.J. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat. Struct. Mol. Biol. 2010, 17:1043-1050.
57. Xu G., Zhang J. Human coding RNA editing is generally nonadaptive. Proc. Natl. Acad. Sci. USA 2014, 111:3769-3774.
58. Zhang Z., Carmichael G.G. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001, 106:465-475.
59. Zhang Q., Xiao X. Genome sequence-independent identification of RNA editing sites. Nat. Methods 2015, 12:347-350.